Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03689140 Completed - Usual Care Clinical Trials

Mobile Health Intervention for Family Smoking Cessation in Romania

Start date: January 28, 2019
Phase: N/A
Study type: Interventional

The objectives of this study are to determine in a randomized controlled trial (RCT) whether a mobile health (mHealth) couples intervention shows promise in increasing smoking cessation among pregnant couples who smoke and to build mHealth research capacity in Romania. The intervention will be novel in its use of the unique functionality of smartphones, its emphasis on the dyadic efficacy for smoking cessation, and the focus on pregnant couples. Our aims are to (1) Test the implementation feasibility, acceptability, and initial efficacy of a culturally-adapted mHealth smoking cessation intervention among couples during pregnancy and postpartum in Romania. (2) Develop mHealth research capacity by enhancing individual and institutional research capabilities in Romania and expanding the existing international research network.

NCT ID: NCT03688724 Completed - Clinical trials for Brachial Plexus Block

Perioperative Diaphragm Point of Care Ultrasound

DPOCUS
Start date: October 15, 2018
Phase:
Study type: Observational [Patient Registry]

It is a prospective observational study of a cohort of patients who underwent brachial plexus blockage above the clavicle, and in which diaphragmatic function is observed in both hemidiaphragms by ultrasound (using Diaphragm Thickening Fraction), which allows to obtain the real incidence of Hemidiaphragm palsy in these patients, and estimate the perioperative evolution of both hemidiaphragms. Hemidiaphragm palsy after brachial plexus block above the clavicle (BPBAC) is frequent, but few patients develop postoperative pulmonary complications (PPC). Little attention has been paid to the contralateral hemidiaphragm as part of the global diaphragmatic function. After BPBAC, global diaphragm function reduces due to ipsilateral hemidiaphragm reduction, but less than expected due to the increase in the contralateral hemidiaphragm function. As a part of the diaphragm function, the contralateral hemidiaphragm function plays a relevant role in the appearance of PPC.

NCT ID: NCT03688152 Completed - Clinical trials for Refractory Diffuse Large B-Cell Lymphoma

A Safety and Tolerability Study of INCB053914 in Combination With INCB050465 in Diffuse Large B-Cell Lymphoma

Start date: December 3, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of INCB053914 in combination with INCB050465 in relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

NCT ID: NCT03687996 Completed - Clinical trials for Descemet's Stripping Automated Endothelial Keratoplasty

Pratical Assessment of DSAEK in the Management of Endothelial Decompensation Following Penetrating Keratoplasty

MADE
Start date: January 1, 2015
Phase:
Study type: Observational

Reporting our anatomical and functional results and the possible complications of the first six Descemet's stripping endothelial keratoplasty (DSAEK) performed in our department secondary to endothelial decompensation after penetrating keratoplasty.

NCT ID: NCT03687775 Completed - Joint Instability Clinical Trials

CMC I Stability Intraoperative

Start date: September 17, 2018
Phase:
Study type: Observational

The goal of the current study is to objectively measure intraoperative the initial thumb stability after trapezium removal when performing trapeziectomy, alone or in combination with suspension and tendon interposition and to evaluate if there are differences in the stability between the patients and with the different surgical steps. Additionally, the subjective stability rating of the surgeon will be compared with the objective measures and if there is a correlation between clinical/patient-related parameters and the measured intraoperative stability.

NCT ID: NCT03687632 Completed - Clinical trials for Persistent Corneal Epithelial Defect

ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects

Start date: June 10, 2019
Phase: Phase 2
Study type: Interventional

The primary aim of the study is to evaluate the clinical response of ST266 treated subjects with persistent corneal epithelial defects during 28 days of therapy. The secondary endpoint is the response rate within 14 days of treatment.

NCT ID: NCT03687567 Completed - Clinical trials for Thalassemia,Embryonic Development,Reproductive Sterility and Infertility

A Retrospective Study on the Effect of HBA or HBB Genetic Defects on Early Embryonic Development

Start date: September 1, 2013
Phase:
Study type: Observational

Thalassemia is an anemia or pathological state caused by compounding absently or inadequately of one or more globin chains of hemoglobin due to the defects of the globin gene,and the carrying rate is high in southern China. Although there are many studies of Thalassemia, the relationship between the globin gene defects and the early embryo development has not been reported. This study intends to carry out a retrospective analysis on the embryonic development of the patients with thalassemia assisted by PGD from January 1, 2011 to now in our hospital, to explore whether the HBA or HBB gene defects have a certain influence on the early embryo development, so as to accumulate certain data for reproductive health research.

NCT ID: NCT03687554 Completed - Healthy Volunteers Clinical Trials

Effect of Venglustat in Patients With Renal Impairment

Start date: October 5, 2018
Phase: Phase 1
Study type: Interventional

Primary Objective: To study the effect of mild, moderate and severe renal impairment on the pharmacokinetics (PK) of Venglustat following a single dose. Secondary Objective: To assess the tolerability of Venglustat given as a single dose in subjects with mild, moderate and severe renal impairment in comparison with matched subjects with normal renal function.

NCT ID: NCT03687515 Completed - Clinical trials for Chronic Rhinosinusitis With Polyposis

Efficacy and Safety of Budesonide Inhalation Suspension for the Treatment of Chronic Rhinosinusitis With Polyposis.

Start date: January 1, 2015
Phase: Phase 3
Study type: Interventional

Topical and systemic steroids constitute the first choice in medical treatment for nasal polyps. This study aimed to evaluate the efficacy and safety of a short course of budesonide inhalation suspension via transnasal nebulization in the preoperative management of chronic rhinosinusitis with nasal polyposis. The second aim was to compare budesonide inhalation suspension with budesonide aqueous nasal spray and oral prednisone in nasal polyp treatment.

NCT ID: NCT03687242 Completed - Clinical trials for Congenital Adrenal Hyperplasia

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

Start date: September 6, 2018
Phase: Phase 2
Study type: Interventional

This is a Phase 2 study of SPR001 for the treatment of classic CAH that will provide 12 weeks of open-label treatment to eligible subjects.